NZ237447A - Plasmodium sporozoite antigen, dna, vectors, transformed microorganisms and preparation, immunogenic compositions and polypeptides containing epitopes of the antigen - Google Patents
Plasmodium sporozoite antigen, dna, vectors, transformed microorganisms and preparation, immunogenic compositions and polypeptides containing epitopes of the antigenInfo
- Publication number
- NZ237447A NZ237447A NZ237447A NZ23744791A NZ237447A NZ 237447 A NZ237447 A NZ 237447A NZ 237447 A NZ237447 A NZ 237447A NZ 23744791 A NZ23744791 A NZ 23744791A NZ 237447 A NZ237447 A NZ 237447A
- Authority
- NZ
- New Zealand
- Prior art keywords
- antigen
- vectors
- dna
- preparation
- immunogenic compositions
- Prior art date
Links
- 241000224016 Plasmodium Species 0.000 title 1
- 101710152205 Sporozoite antigen Proteins 0.000 title 1
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 230000002163 immunogen Effects 0.000 title 1
- 244000005700 microbiome Species 0.000 title 1
- 239000000203 mixture Substances 0.000 title 1
- 229920001184 polypeptide Polymers 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 239000013598 vector Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/44—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from protozoa
- C07K14/445—Plasmodium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/02—Antiprotozoals, e.g. for leishmaniasis, trichomoniasis, toxoplasmosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/20—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans from protozoa
- C07K16/205—Plasmodium
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/35—Fusion polypeptide containing a fusion for enhanced stability/folding during expression, e.g. fusions with chaperones or thioredoxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Tropical Medicine & Parasitology (AREA)
- General Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Animal Behavior & Ethology (AREA)
- Immunology (AREA)
- Physics & Mathematics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Plant Pathology (AREA)
- Gastroenterology & Hepatology (AREA)
- Microbiology (AREA)
- Public Health (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH97090 | 1990-03-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
NZ237447A true NZ237447A (en) | 1993-05-26 |
Family
ID=4199439
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NZ237447A NZ237447A (en) | 1990-03-23 | 1991-03-15 | Plasmodium sporozoite antigen, dna, vectors, transformed microorganisms and preparation, immunogenic compositions and polypeptides containing epitopes of the antigen |
Country Status (9)
Country | Link |
---|---|
EP (1) | EP0447956A1 (en) |
JP (1) | JPH0686679A (en) |
AU (1) | AU637468B2 (en) |
CA (1) | CA2037151A1 (en) |
IE (1) | IE910966A1 (en) |
IL (1) | IL97578A0 (en) |
NZ (1) | NZ237447A (en) |
PT (1) | PT97117A (en) |
ZA (1) | ZA911950B (en) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU3355095A (en) * | 1994-09-02 | 1996-03-27 | Meiji Milk Products Company Limited | Diagnostic drug for chlamydia infection |
EP1221968B1 (en) * | 1999-10-13 | 2010-01-13 | Novartis Vaccines and Diagnostics, Inc. | Method of obtaining cellular immune responses from proteins |
CA2713879C (en) * | 2008-02-01 | 2020-01-07 | Alpha-O Peptides Ag | Self-assembling peptide nanoparticles useful as vaccines |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ATE78869T1 (en) * | 1985-02-07 | 1992-08-15 | Smithkline Beecham Corp | MALARIA VACCINE. |
GB8615068D0 (en) * | 1986-06-20 | 1986-07-23 | Wellcome Found | Vaccines |
HUT51332A (en) * | 1987-01-30 | 1990-04-28 | Smithkline Biolog | Process for expressing p.falciparum cirkumsporozoita protein by yeast |
AU625713B2 (en) * | 1988-02-19 | 1992-07-16 | Microgenesys, Inc. | Method for producing recombinant protein derived from the circumsporozoite gene of plasmodium falciparum |
FR2645877B1 (en) * | 1989-04-12 | 1991-07-05 | Pasteur Institut | MOLECULES COMPRISING AT LEAST ONE PEPTIDE SEQUENCE CARRYING ONE, OR SEVERAL, CHARACTERISTIC EPITOPE OF A PROTEIN PRODUCED BY P. FALCIPARUM AT THE SPOROZOITE STAGE AND IN THE HEPATOCYTES |
AU7163091A (en) * | 1989-12-12 | 1991-07-18 | Biomedical Research Institute | Novel malarial sporozoite peptide antigens |
-
1991
- 1991-02-26 CA CA002037151A patent/CA2037151A1/en not_active Abandoned
- 1991-03-14 EP EP91103900A patent/EP0447956A1/en not_active Withdrawn
- 1991-03-15 ZA ZA911950A patent/ZA911950B/en unknown
- 1991-03-15 NZ NZ237447A patent/NZ237447A/en unknown
- 1991-03-18 AU AU73589/91A patent/AU637468B2/en not_active Expired - Fee Related
- 1991-03-18 IL IL97578A patent/IL97578A0/en unknown
- 1991-03-22 JP JP3059119A patent/JPH0686679A/en active Pending
- 1991-03-22 PT PT97117A patent/PT97117A/en not_active Application Discontinuation
- 1991-03-22 IE IE096691A patent/IE910966A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
CA2037151A1 (en) | 1991-09-24 |
ZA911950B (en) | 1991-11-27 |
AU637468B2 (en) | 1993-05-27 |
PT97117A (en) | 1991-11-29 |
IL97578A0 (en) | 1992-06-21 |
JPH0686679A (en) | 1994-03-29 |
AU7358991A (en) | 1991-10-03 |
EP0447956A1 (en) | 1991-09-25 |
IE910966A1 (en) | 1991-09-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA913291B (en) | Hair-treating microemulsion composition and method of preparing and using the same | |
IL105770A0 (en) | Vaccine compositions and their preparation | |
GB8924438D0 (en) | Vaccine composition | |
HK1000113A1 (en) | Vaccine composition | |
IL70776A (en) | Recombinant dna molecule encoding at least one polypeptide displaying the immunogenicity of at least one merozoite antigen or asexual blood stage antigen of p.falciparum,vectors comprising the dna molecule,host cells transformed thereby,immunogenic polypeptides produced by host cells and compositions containing the polypeptides | |
IL98845A0 (en) | Coconjugate vaccines comprising immunogenic protein,hiv related peptides,and anionic moieties,their preparation and pharmaceutical compositions containing them | |
NZ233085A (en) | Eimeria tenella 100kd immunogenic peptide, vectors, antibodies and vaccines | |
IL102448A0 (en) | Immunogenic polypeptide,its production and coccidiosis vaccine containing it | |
NZ234049A (en) | Peptide epitopes of, and antibodies to htlv-1 | |
NZ237447A (en) | Plasmodium sporozoite antigen, dna, vectors, transformed microorganisms and preparation, immunogenic compositions and polypeptides containing epitopes of the antigen | |
EP0290565A4 (en) | Vaccine containing tick antigens. | |
IL71953A (en) | Malaria associated antigen,process for preparation thereof and vaccine comprising it | |
ZA916433B (en) | Novel pyrrolobenzimidazoles,imidazobenzoxazinones and imidazoquinolones,process for their preparation and their use and preparations containing the compounds | |
AP9000165A0 (en) | Vaccine composition | |
ZA874920B (en) | Immunogenic fraction active against bilharzioses,its preparation,and immunizing compositions containing it | |
NZ223624A (en) | Peptide immunogen from streptococcus mutans, vaccines and antibodies | |
IL81920A (en) | Vaccines comprising an antigen and interferon-ypsilon and their preparation | |
NZ233255A (en) | Plasmodium cs protein analogues lacking one or more of the repeat epitopes, and containing at least one nonrepeat flanking epitope | |
IL104745A0 (en) | 90k tumor-associated antigen,method for the preparation thereof and pharmaceutical compositions containing the same | |
GB8919064D0 (en) | Plasmodium merozoite rhoptries antigen | |
IL93589A0 (en) | Bisphenethanolamine,its preparation and preparations containing it | |
HU9201115D0 (en) | Alchemilla-extract, process for its preparation, and cosmetical preparations made of alchemilla extract | |
GB2238959B (en) | Antigen and conjugates thereof for suppressing immune response | |
GB8700406D0 (en) | Babesia divergens antigen & vaccine | |
GB2248186B (en) | Preparation of vaccines |